Loading clinical trials...
Loading clinical trials...
This study compares several different antiretroviral adherence measures, including digital pills, in HIV+ individuals who are maintained on opioid analgesics.
This study compares digital pills, electronic pill bottles, self-report, and dried blood spots, in measuring adherence to antiretroviral medications containing emtricitabine and tenofovir.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University of Miami
Miami, Florida, United States
Start Date
February 1, 2021
Primary Completion Date
March 12, 2025
Completion Date
April 30, 2025
Last Updated
August 3, 2025
31
ACTUAL participants
MyTPill, a digital pill
DEVICE
Lead Sponsor
Ohio State University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions